• SENSEX 80,641.07
    -155.77 (--0.19%)
  • BANKNIFTY 54,271.40
    -648.10 (--1.18%)
  • Polycab India
    6,078.00 7,607.15(%)
  • Cipla
    1,495.05 1,310.05(%)
  • Hind.Aeronautics
    4,491.00 3,045.95(%)
  • Tata Motors
    645.50 542.55(%)
  • Tejas Networks
    740.00 1,495.10(%)
  • M & M
    3,159.00 3,276.30(%)
  • Mazagon Dock
    2,933.45 1,046.00(%)
  • Jio Financial
    250.35 198.60(%)
  • Coforge
    7,388.00 4,291.05(%)
  • Sonata Software
    382.00 286.40(%)
  • Yes Bank
    19.44 27.41(%)
  • Suzlon Energy
    53.42 37.95(%)
  • St Bk of India
    771.15 679.65(%)
  • Ather Energy
    300.00 300.00(%)
  • CCL Products
    707.00 854.00(%)
  • Swiggy
    332.65 303.05(%)
  • Tata Steel
    145.35 184.60(%)
  • Bank of Baroda
    212.10 190.70(%)
  • Eternal Ltd
    231.75 146.85(%)
  • Ujjivan Small
    40.71 30.85(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • PPI
  • BSE Code : 2393.0
  • ISIN : INE107F01022
231.18 -11 (-4.54%)
  • As on 06 May 2025 (EOD)
  • Today’s Low

    227.10
  • Today’s High

    245.29
  • Open

    242.17
  • Perv Close

    242.17
  • 52W Low

    131.20
  • 52W High

    323.53

Key Indicators

  • P/E(TTM)

    41.40

  • Mar.Cap (₹Cr.)

    757.59

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.83

  • Debt-Equity Ratio

    -4.54

  • AGM Date

    06-May-2025

  • EPS

    5.60

  • P/E Ratio

    41.40

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    757.59

  • RONW (%)

    49.77

  • ROCE (%)

    33.46

Score Board

  • Equity (₹ in Cr.)

    32.77

  • BV (₹)

    11.80

  • Sales( ₹ in Cr.)

    575.65

  • NP (in Cr.)

    29.91

  • NP Var(%)

    397.0

  • Div%

    0.0

  • CPS (₹)

    13.10

  • EPS (₹)

    9.10

  • Traded Value (₹ in Lakhs)

    759.78

  • 52 Week High

    323.53

  • 52 Week Low

    131.20

  • Price BSE

    232.0

  • Price NSE

    231.00

  • Market Capital( in Cr.)

    759.78

  • P/C Ratio

    17.70

  • P/E Ratio

    25.40

  • Price Vs.BV

    9.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 575.65 499.65 511.19 392.52 367.45 391.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 575.65 499.65 511.19 392.52 367.45 391.37
Other Income 2.99 0.91 77.88 2.40 83.78 9.33
Stock Adjustments 3.89 -29.13 24.79 7.20 -5.99 5.06
Total Income 582.53 471.43 613.86 402.12 445.24 405.76
EXPENDITURE :            
Raw Materials 306.52 274.31 325.07 228.53 169.75 201.26
Power and Fuel Cost 24.58 20.59 18.41 17.13 15.38 14.46
Employee Cost 86.92 81.00 74.81 64.15 67.48 75.89
Other Manufacturing Expenses 13.32 11.43 12.66 9.98 13.77 7.98
Selling and Administration Expenses 58.51 45.16 55.34 45.49 55.36 63.70
Miscellaneous Expenses 19.69 15.45 14.36 16.42 16.29 17.59
Employee Benefit Expenses 86.92 81.00 74.81 64.15 67.48 75.89
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 509.54 447.94 500.65 381.70 338.02 380.89
Operating Profit 72.99 23.49 113.19 20.42 107.23 24.86
Interest 29.18 21.39 20.61 23.07 32.87 39.88
Gross Profit 43.81 2.10 92.58 -2.65 74.36 -15.02
Depreciation 13.03 12.38 11.45 9.75 9.68 9.97
Profit Before Tax 30.78 -10.28 81.13 -12.40 64.68 -24.99
Current Tax 0.00 0.00 0.00 2.27 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.11 -0.35 -2.07 0.21 -0.14
Reported Net Profit 30.40 -10.40 81.47 -12.61 64.46 -24.85
Extraordinary Items 0.49 -0.31 76.06 1.21 82.62 0.12
Adjusted Net Profit 29.91 -10.09 5.41 -13.82 -18.16 -24.97
Adjustment below Net Profit -0.59 0.26 0.80 -0.44 -0.46 0.31
P & L Balance brought forward -168.14 -158.01 -240.28 -227.23 -291.23 -266.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -138.34 -168.14 -158.01 -240.28 -227.23 -291.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.28 -3.18 24.94 -5.04 25.79 -10.48
Earnings Per Share(Adj)-Unit Curr 9.28 -3.18 24.94 -5.04 25.79 -10.48
Book Value 6.70 -2.26 0.57 -52.23 -47.14 -77.40
Book Value(Adj)-Unit Curr 6.70 -2.26 0.57 -52.23 -47.14 -77.40

Shareholding Pattern

  • Promoter Group

    39.76%

  • Public Share Holding

    60.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,024,000 9.23 3,024,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,024,000 9.23 3,024,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,005,561 30.53 10,005,561 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,005,561 30.53 10,005,561 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 521 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 509,076 1.55 509,076 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 66 0.00 66 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 509,663 1.56 509,142 10
2] Non Institution
Bodies Corporate 2,941,043 8.97 2,939,690 178
Clearing Members 81,657 0.25 81,657 33
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 467,351 1.43 465,232 221
Foreign Non Institution Other 94,680 0.29 0 1
Hindu Undivided Families 934,923 2.85 934,857 529
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,322,881 19.29 6,322,881 90
Individuals holding nominal share capital up to Rs. 1 lakh 7,368,574 22.49 7,243,082 16,797
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 452,715 1.38 452,715 4
Sub Total 19,231,274 58.68 19,007,564 17,877
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 32,770,498 100.00 29,522,267 17,889

Company Background

Wanbury LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wanbury Ltd
  • BSE Code : 2393.0
  • ISIN : INE107F01022
  • Incorporation Year

    1988

  • Registered Office

    BSEL Tech Park B-Wing 10th Flr
    Sector 30 A Opp Vashi Rly Stat, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-67942222

  • FAX

    91-22-67942111/333

  • Chairman

    K Chandran

  • Managing Director

  • Company Secretary

    Jitendra J Gandhi

  • Auditor

    V Parekh & Associates/Kapoor & Parekh Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

Wanbury Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wanbury 231.85 578.64 575.65 41.40 32.14
Abbott India 30,145.75 6,097.18 5,848.91 48.00 44.71
Astrazeneca Phar 8,201.30 1,330.33 1,295.53 211.43 33.26
P & G Health Ltd 5,038.45 1,166.89 1,151.26 35.35 39.76
Glaxosmi. Pharma 2,840.55 3,530.73 3,407.25 56.48 44.44
Cipla 1,510.70 17,645.00 16,574.34 25.90 20.10
Amrutanjan Healt 673.05 437.58 421.23 39.45 20.84
Fermenta Biotec. 265.40 315.24 307.09 25.16 4.10
Guj. Themis Bio. 264.40 174.19 169.82 54.74 44.82
Bliss GVS Pharma 113.50 638.96 605.46 25.97 11.19
Ambalal Sarabhai 35.40 11.70 3.81 15.13 1.92